Zinc-altered immune function and cytokine production

被引:165
作者
Rink, L [1 ]
Kirchner, H [1 ]
机构
[1] Med Univ Lubeck, Sch Med, Inst Immunol & Transfus Med, D-23538 Lubeck, Germany
关键词
trace elements; immunology; cell biology; human; review;
D O I
10.1093/jn/130.5.1407S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Although the intriguing role of zinc as an essential trace element for immune function is well established, particular progress in determining the molecular principles of action of this ion was made recently. Leukocyte responsiveness is delicately regulated by zinc concentration. Zinc deficiency as well as supraphysiologic levels impair immune function. Furthermore, the activities of many immunostimulants frequently used in immunologic studies are influenced by zinc concentration. Therefore, our knowledge from in vitro studies is widely dependent on the zinc concentration, acid when not in physiologic range, immunologic responses are artificially low. Decreased production of TH1 cytokines and interferon-alpha by leukocytes in the healthy elderly person is correlated with low zinc serum level. The defect in interferon-alpha production is reconstituted by the addition of physiologic amounts of zinc in vitro. interestingly, zinc induces cytokine production by isolated leukocytes. Zinc induces monocytes to produce interleukin-l, interleukin-6 and tumor necrosis factor-alpha in peripheral blood mononuclear cells and separated monocytes. This effect is higher in serum-free medium. However, only in the presence of serum does zinc also induce T cells to produce lymphokines. This effect on T cells is mediated by cytokines produced by monocytes. Stimulation also requires cell-to-cell contact of monocytes and T cells. Information is presented to illustrate the concepts that the zinc concentration must be taken into account whenever in vitro studies are made or complex alterations of immune functions are observed in vivo.
引用
收藏
页码:1407S / 1411S
页数:5
相关论文
共 93 条
[51]   THE PHENOMENON OF THE ACUTE PHASE RESPONSE [J].
KUSHNER, I .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 389 (JUN) :39-48
[52]  
Lavin M, 1993, PROGRAMMED CELL DEAT, P73
[53]   ADMISSION CRITERIA FOR IMMUNOGERONTOLOGICAL STUDIES IN MAN - THE SENIEUR PROTOCOL [J].
LIGTHART, GJ ;
CORBERAND, JX ;
FOURNIER, C ;
GALANAUD, P ;
HIJMANS, W ;
KENNES, B ;
MULLERHERMELINK, HK ;
STEINMANN, GG .
MECHANISMS OF AGEING AND DEVELOPMENT, 1984, 28 (01) :47-55
[54]  
MATHE G, 1985, MED ONCOL TUMOR PHAR, V2, P203
[55]   Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses [J].
Mingari, MC ;
Moretta, A ;
Moretta, L .
IMMUNOLOGY TODAY, 1998, 19 (04) :153-157
[56]   REVERSIBILITY OF THE THYMIC INVOLUTION AND OF AGE-RELATED PERIPHERAL IMMUNE DYSFUNCTIONS BY ZINC SUPPLEMENTATION IN OLD MICE [J].
MOCCHEGIANI, E ;
SANTARELLI, L ;
MUZZIOLI, M ;
FABRIS, N .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (09) :703-718
[57]   BENEFIT OF ORAL ZINC SUPPLEMENTATION AS AN ADJUNCT TO ZIDOVUDINE (AZT) THERAPY AGAINST OPPORTUNISTIC INFECTIONS IN AIDS [J].
MOCCHEGIANI, E ;
VECCIA, S ;
ANCARANI, F ;
SCALISE, G ;
FABRIS, N .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (09) :719-727
[58]   Zinc gluconate lozenges for treating the common cold - A randomized, double-blind, placebo-controlled study [J].
Mossad, SB ;
Macknin, ML ;
Medendorp, SV ;
Mason, P .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (02) :81-+
[59]  
MURTHY ARK, 1993, J IMMUNOL, V151, P6291
[60]   ZINC EXCHANGE BY BLOOD-CELLS IN NEARLY PHYSIOLOGICAL STANDARD CONDITIONS [J].
NABER, THJ ;
VANDENHAMER, CJA ;
VANDENBROEK, WJM ;
ROELOFS, H .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1994, 46 (1-2) :29-50